EBE Annual Meeting 2016: IMI – Opportunities and Challenges for developing Advanced Therapies
Watch here the recording of the live broadcast
IMI – opportunities and challenges for developing Advanced Therapies (17h00 – 19h00 CET)
A keynote speech by Pierre Meulien, Executive Director IMI, followed by a moderated panel discussion on the opportunities for EBE members.
CEO TiGenix and incoming EBE President
Global Head Discovery & Investigative Safety and Therapeutic Areas, Novartis Pharma
CEO Ixaltis and the outgoing EBE president